Progressive Multifocal Leukoencephalopathy (PML): Difference between revisions
No edit summary |
|||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{ICD10 dx | |||
|ICD10 Code=A81.2 | |||
}} | |||
{{ICD10 category|Infectious disease}} | |||
{{ICD10 category|Neuro}} | |||
{{ICD10 category|Virus}} | |||
{{ICD10 category|Potential infection}} | |||
{{ICD10 transition status | {{ICD10 transition status | ||
| OldDxArticle =Neurologic Other | | OldDxArticle =Neurologic Other | ||
| Line 4: | Line 11: | ||
| InitialEditorAssigned = Allyson Alcudia | | InitialEditorAssigned = Allyson Alcudia | ||
}} | }} | ||
== Additional Info == | == Additional Info == | ||
*PML is a rare and often fatal neurologic disease marked by progressive, immune-mediated, multifocal damage to the white matter of the brain. | *PML is a rare and often fatal neurologic disease marked by progressive, immune-mediated, multifocal damage to the white matter of the brain. | ||
* also known as vanishing white matter disease (VWM) | |||
*Most cases are caused by JC virus, however, an increasing other cause is new immune-modifying drugs. | *Most cases are caused by JC virus, however, an increasing other cause is new immune-modifying drugs. | ||